Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

System Suitability (CompRef) Study: Human-in-mouse xenograft breast cancer tumor samples

ABSTRACT: The objective of the "System Suitability (CompRef) Study" was to validate mass spectrometry protocols used at each Proteome Characterization Center (PCC).

Dataset imported into MassIVE from https://cptac-data-portal.georgetown.edu/cptac/s/S010 on 10/22/19

INSTRUMENT(S): LTQ Orbitrap Velos, Q Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) Mus Musculus (ncbitaxon:10090)

SUBMITTER: Richard Smith Xian Chen Steven A. Carr Daniel Chan R. Reid Townsend Daniel C Liebler Hui Zhang

PROVIDER: MSV000084497 | MassIVE | Wed Oct 23 16:58:00 BST 2019

SECONDARY ACCESSION(S): PXD016113

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

CPTAC, TCGA Breast Cancer Proteome Study Comparison and Reference Samples (CompRef)

Project description:Comparison and Reference (CompRef) Samples, initially characterized in the <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S010" target="_blank">System Suitability Study</a>, were analyzed along with the TCGA Breast Cancer tumor samples. These 5 iTRAQ experiments include proteome and phosphoproteome interrogation of both the P5 (basal) and P6 (luminal) human-in-mouse xenograft breast carcinoma pooled samples. The CompRef experiments were intercalated between the TCGA Breast Cancer experiments to monitor the consistency of laboratory protocols and mass spectrometry instrument performance.<ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S018">https://cptac-data-portal.georgetown.edu/cptac/s/S018</a> on 08/25/19</li></ul>

2019-08-25 | MSV000084233 | MassIVE

CPTAC, TCGA Colorectal Cancer Proteome Study Comparison and Reference Samples (CompRef)

Project description:Comparison and Reference (CompRef) Samples, initially characterized in the <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S010">System Suitability Study</a>, were analyzed along with the <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S016">TCGA colorectal cancer tumor samples</a> and with the <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S019">normal colon epithelium samples</a>. These interstitial CompRef experiments are global proteomic profiling of the P6 (luminal) and P5 (basal) human-in-mouse xenograft breast carcinoma pooled samples.One CompRef sample was run after every 5 samples of TCGA colorectal cancer tumor tissue, alternating between the P6 and P5 CompRef samples to generate 20 total data sets (designated as 01CompRef_P6_VU through 20CompRef_P5_VU).Twelve CompRef samples were run with the 30 normal colon epithelium samples to produce 12 data sets (designated as 21CompRef_P6_VU through 32CompRef_P5_VU).These experiments were used to monitor the consistency of laboratory protocols and mass spectrometry instrument performance during the TCGA colorectal cancer analysis.<ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S017" target="_blank">https://cptac-data-portal.georgetown.edu/cptac/s/S017</a> on 08/31/18</li></ul>

2018-08-31 | MSV000082875 | MassIVE

CPTAC, TCGA Ovarian Cancer Proteome Study Comparison and Reference Samples (CompRef)

Project description:Comparison and Reference (CompRef) Samples, initially characterized in the <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S010" target="_blank">System Suitability Study</a>, were analyzed along with the TCGA Ovarian Cancer tumor samples. Pacific Northwest National Laboratory conducted iTRAQ experiments that included proteome (5 Data sets) and phosphoproteome (4 Data sets) interrogation of both the P5 (basal) and P6 (luminal) human-in-mouse xenograft breast carcinoma pooled samples. Johns Hopkins University performed 6 iTRAQ proteome experiments. The CompRef experiments were intercalated between the TCGA Ovarian Cancer experiments to monitor the consistency of laboratory protocols and mass spectrometry instrument performance.<ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S021">https://cptac-data-portal.georgetown.edu/cptac/s/S021</a> on 08/26/19</li></ul>

2019-08-26 | MSV000084236 | MassIVE

Time-Dependent Proteome Study: Human-in-mouse xenograft breast cancer tumor samples (0, 5, 30, 60 min)

Project description:The objective of the Time-Dependent Proteome Study was to evaluate changes in the proteome and phosphoproteome when there is a delay in freezing tissues following sample (tumor) excision. The biospecimens used are from human-in-mouse breast cancer tumor samples. <a href="http://www.ncbi.nlm.nih.gov/pubmed/24719451" target="_blank">Ref: Mertins P et al., (2014) Mol Cell Proteomics, Apr 9. E-Publication</a><ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S011">https://cptac-data-portal.georgetown.edu/cptac/s/S011</a> and <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S012">https://cptac-data-portal.georgetown.edu/cptac/s/S012</a> on 08/29/19</li></ul>

2019-08-30 | MSV000084260 | MassIVE

CPTAC System Suitability (CompRef) Study: Proteome, VU

Project description:The objective of the "System Suitability (CompRef) Study" was to validate mass spectrometry protocols used at each Proteome Characterization Center (PCC). Please include this attribution in publications, "Data used in this publication was created by the Clinical Proteomics Tumor Analysis Consortium (NCI/NIH)."

2014-09-16 | PXD001006 | Pride

CPTAC System Suitability (CompRef) Study: Proteome, PNNL

2014-09-16 | PXD000966 | Pride

CPTAC System Suitability (CompRef) Study: Phosphoproteome, PNNL

2014-09-16 | PXD001000 | Pride

Time-Dependent Proteome Study: Human colorectal tumor samples (0, 10, 30, 60 min)

Project description:The objective of the Time-Dependent Proteome Study was to evaluate changes in the proteome and phosphoproteome when there is a delay in freezing tissues following sample (tumor) excision. The biospecimens used are from snap-frozen colon adenocarcinoma core biopsy punches. <a href="http://www.ncbi.nlm.nih.gov/pubmed/25670172" target="_blank">Ref: Gajadhar, A.S., et al., (2015) Cancer Res. Apr 1;75(7):1495-503. Epub 2015 Feb 10.</a><ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S023">https://cptac-data-portal.georgetown.edu/cptac/s/S023</a> on 08/28/19</li></ul>

2019-08-28 | MSV000084243 | MassIVE

CPTAC System Suitability (CompRef) Study: Phosphoproteome, PNNL

| MSV000080134 | MassIVE

CPTAC System Suitability (CompRef) Study: Proteome, PNNL

| MSV000080135 | MassIVE